Cargando...

PX-478, an inhibitor of hypoxia-inducible factor-1α, enhances radiosensitivity of prostate carcinoma cells

Overexpression of hypoxia-inducible factor-1α (HIF-1α) in human tumors is associated with poor prognosis and poor outcome to radiation therapy. Inhibition of HIF-1α is considered as a promising approach in cancer therapy. The purpose of this study was to test the efficacy of a novel HIF-1α inhibitor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Cancer
Autores principales: Palayoor, Sanjeewani T., Mitchell, James B., Cerna, David, DeGraff, William, John-Aryankalayil, Molykutty, Coleman, C. Norman
Formato: Artigo
Lenguaje:Inglês
Publicado: 2008
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4277812/
https://ncbi.nlm.nih.gov/pubmed/18729192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.23807
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!